MURRAY ADRIAN COTTER
Pharmacy in Ann Arbor, MI
License number
Michigan 5315014120
Issued Date
Jun 20, 2003
Expiration Date
Jun 30, 2004
Category
Pharmacy
Type
CS - 1
Address
Address
Ann Arbor, MI 48106
Personal information
See more information about MURRAY ADRIAN COTTER at radaris.comName
Address
Phone
16926 Locherbie Ave, Beverly Hills, MI 48025
3921 Benjamin Ave #B4, Royal Oak, MI 48073
4875 Charing Cross Rd, Bloomfield, MI 48304
5825 Staghorn Dr, Ypsilanti, MI 48197
7348 Preserve Dr S, Bay Harbor, MI 49770
Professional information
See more information about MURRAY ADRIAN COTTER at trustoria.com
Methods To Inhibit Or Enhance The Binding Of Viral Dna To Genomic Host Dna
Methods To Inhibit Or Enhance The Binding Of Viral Dna To Genomic Host Dna
US Patent:
6482587, Nov 19, 2002
Filed:
Oct 1, 1999
Appl. No.:
09/410399
Inventors:
Erle S. Robertson - Plymouth MI
Murray A. Cotter - Ann Arbor MI
Murray A. Cotter - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 170
US Classification:
435 5, 424 92, 435 721, 435325, 530350
Abstract:
This invention relates to novel reagents and methods for the screening of compounds that may be agonistic or antagonistic to the binding of viral DNA to the chromosomes of host cells, that may be used in gene therapy and that may be used to treat tumor viruses.
Methods To Inhibit Or Enhance The Binding Of Viral Dna To Genomic Host Dna
Methods To Inhibit Or Enhance The Binding Of Viral Dna To Genomic Host Dna
US Patent:
2003013, Jul 17, 2003
Filed:
Nov 14, 2002
Appl. No.:
10/294804
Inventors:
Erle Robertson - Plymouth MI, US
Murray Cotter - Ann Arbor MI, US
Murray Cotter - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K039/12, A61K039/245, A61K039/25, C12N007/00, C12N007/01, C12N015/00, C12N015/09, C12N015/63, C12N015/70, C12N015/74
US Classification:
424/199100, 435/320100, 435/235100, 424/230100
Abstract:
This invention relates to novel reagents and methods for the screening of compounds that may be agonistic or antagonistic to the binding of viral DNA to the chromosomes of host cells, that may be used in gene therapy and that may be used to treat tumor viruses.